Full-Time

Manufacturing Process Technician

Ftc

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Junior, Mid

Dublin, Ireland

Category
Biology Lab & Research
Biology & Biotech
Required Skills
SAP Products
Requirements
  • Educated to diploma level or equivalent in an appropriate discipline.
  • Applicants should have relevant experience of operation of a manufacturing function in a sterile pharmaceutical manufacturing or similar environment.
  • Be a results oriented person with excellent organizational, communicational and team development skills with an ability to successfully interact with people, create a team environment and generate co-operation.
  • Demonstrated ability to deliver to team, site and personal objectives.
  • Demonstrated understanding and use of RFT techniques and lean manufacturing concepts.
  • Applicants will be required to pass an eye test as a requirement for this role.
Responsibilities
  • Manufacturing Process, Packing and Inspections Technicians are required to work a variety of shift patterns examples including days, 2, 3 and 4 Rota shifts.
  • The Manufacturing Process Technicians reporting to the shift manager, will be responsible for one or more of a number of roles relating to the manufacture of sterile parenteral drugs to include but not limited to operation and set up of manufacturing equipment, processing of parts and components for manufacturing, performing transactions in electronic systems such as EBR, LIMS, SAP, etc and cleaning and sanitization of production areas.
  • They will perform all operations with due care and attention and in accordance with Good manufacturing practices and Amgen requirements.
  • They will be involved in problem solving and troubleshooting including initiation and documentation of investigations.
  • They will be responsible for the performance of self-inspection Quality & Safety Audits within their functional area.
  • They will be part of a learning and development program which will include annual reviews and goal setting via the Maximizing Amgen Performance (MAP) process. They will be responsible for the cross training of other colleagues.
  • They will be responsible for the use, review, revision and upgrade of operational documentation and peer review of operations.
  • They will play a key role in the development of the manufacturing systems and will be responsible for continuous improvement initiatives. Proactively identifying operational improvement opportunities or process related issues including escalation & follow up with area Sr. Associate Tech Engineers for effective resolution and implementation.
  • They will be champions for safe working practices and safety initiatives within their functional area.
  • They will carry out any sampling, testing and inspections that may be required. They will carry out calibration and maintenance of test equipment.
  • Contribute and assist with Corporate, FDA, IMB Auditors and other regulatory bodies during company audits.
  • They will carry out any other duty as may be designated by supervisor/ management from time to time.
Desired Qualifications
  • Experience working with equipment utilised in the manufacture of parenteral products such as autoclaves, filling lines, formulation vessels
  • Good mechanical aptitude
  • Excellent problem solving skills
  • Ability to work in a team environment and on one’s own initiative
  • Experience working in grade A/B areas

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.